TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. By Cancer History Project April 21, 2006
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. By Cancer History Project April 21, 2006
TCL Archive Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber. By Cancer History Project April 14, 2006
TCL Archive NCI Official Says He Hopes to “Put More Money” Into SPOREs. By Cancer History Project April 14, 2006
TCL Archive AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation. By Cancer History Project April 14, 2006
TCL Archive Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs. By Cancer History Project April 14, 2006
TCL Archive Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”. By Cancer History Project April 7, 2006
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
